Efavirenz-associated Stevens-Johnson syndrome.
Colebunders
R
R
Vanwolleghem
T
T
Meurrens
P
P
Moerman
F
F
D000328:Adult; D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D048588:Benzoxazines; D003521:Cyclopropanes; D003622:Dapsone / Q000009:adverse effects; D005260:Female; D006801:Humans; D010078:Oxazines / Q000009:adverse effects*; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced*
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D003622:Dapsone; C098320:efavirenz